{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:22:48Z","timestamp":1773393768209,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Taishan Scholars Program for Young Expert of Shandong Province","award":["tsqn20161064"],"award-info":[{"award-number":["tsqn20161064"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874178"],"award-info":[{"award-number":["81874178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073200"],"award-info":[{"award-number":["82073200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"independent cultivation of innovative team from universities in jinan","award":["2020GXRC023"],"award-info":[{"award-number":["2020GXRC023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12072-021-10249-9","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T18:15:53Z","timestamp":1630692953000},"page":"1413-1420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"15","author":[{"given":"Lun-Jie","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Xiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Niu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Ru","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Guo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5108-1774","authenticated-orcid":false,"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"10249_CR1","unstructured":"Latest global cancer data: Cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020.\u00a0https:\/\/www.iarc.fr\/fr\/news-events\/latest-global-cancer-data-cancer-burden-rises-to-19-3-million-new-cases-and-10-0-million-cancer-deaths-in-2020\/."},{"key":"10249_CR2","doi-asserted-by":"crossref","unstructured":"Liu KX,\u00a0Hong JG,\u00a0Wu R,\u00a0et al. Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-Analysis. Front Oncol. 2021;\u00a011:605648.","DOI":"10.3389\/fonc.2021.605648"},{"issue":"3","key":"10249_CR3","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/hep.30858","volume":"71","author":"JD Yang","year":"2020","unstructured":"Yang JD, Ahmed F, Mara KC, et al. Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease. Hepatology. 2020;71(3):907\u201316.","journal-title":"Hepatology"},{"issue":"8","key":"10249_CR4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/apt.12470","volume":"38","author":"K Zachou","year":"2013","unstructured":"Zachou K, Muratori P, Koukoulis GK, et al. Review article: autoimmune hepatitis - current management and challenges. Aliment Pharmacol Ther. 2013;38(8):887\u2013913.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10249_CR5","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/jgh.14746","volume":"34","author":"T Lv","year":"2019","unstructured":"Lv T, Li M, Zeng N, et al. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. J Gastroenterol Hepatol. 2019;34(10):1676\u201384.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10249_CR6","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.dld.2019.01.015","volume":"51","author":"L Puustinen","year":"2019","unstructured":"Puustinen L, Barner-Rasmussen N, Pukkala E, F\u00e4rkkil\u00e4 M. Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: A nationwide register-based cohort study in Finland. Dig Liver Dis. 2019;51(9):1294\u20139.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10249_CR7","doi-asserted-by":"publisher","first-page":"E222","DOI":"10.1111\/hepr.12973","volume":"48","author":"T Arinaga-Hino","year":"2018","unstructured":"Arinaga-Hino T, Ide T, Miyajima I, et al. Risk of malignancies in autoimmune hepatitis type 1 patients with a long-term follow-up in Japan. Hepatol Res. 2018;48(3):E222\u201331.","journal-title":"Hepatol Res"},{"issue":"9","key":"10249_CR8","first-page":"1022","volume":"52","author":"\u00c5 Danielsson Borss\u00e9n","year":"2017","unstructured":"Danielsson Borss\u00e9n \u00c5, Marschall HU, Bergquist A, et al. Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis. Scand J Gastroenterol. 2017;52(9):1022\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10249_CR9","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.cgh.2013.11.007","volume":"12","author":"FA Castro","year":"2014","unstructured":"Castro FA, Liu X, Forsti A, et al. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease. Clin Gastroenterol Hepatol. 2014;12(6):1038-1045.e1037.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10249_CR10","first-page":"522","volume":"55","author":"JH Ngu","year":"2012","unstructured":"Ngu JH, Gearry RB, Frampton CM, Stedman CAM. Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury. New Zealand Hepatology. 2012;55(2):522\u20139.","journal-title":"New Zealand Hepatology"},{"key":"10249_CR11","doi-asserted-by":"crossref","unstructured":"Werner M, Almer S, Prytz H, et al. Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients. Journal of Hepatology. 2009;50(2):388\u2013393.","DOI":"10.1016\/j.jhep.2008.08.022"},{"issue":"10","key":"10249_CR12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-34.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10249_CR13","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/hep.24005","volume":"52","author":"C Macaron","year":"2010","unstructured":"Macaron C, Hanouneh IA, Zein NN. Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis. Hepatology. 2010;52(6):2240\u20132240.","journal-title":"Hepatology"},{"issue":"7","key":"10249_CR14","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557\u201376.","journal-title":"Gastroenterology"},{"key":"10249_CR15","doi-asserted-by":"crossref","unstructured":"Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2007;5(8):938\u2013945, 945.e931\u2013934.","DOI":"10.1016\/j.cgh.2007.02.039"},{"issue":"3","key":"10249_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1053\/jhep.2003.50093","volume":"37","author":"RF Vel\u00e1zquez","year":"2003","unstructured":"Vel\u00e1zquez RF, Rodr\u00edguez M, Navascu\u00e9s CA, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003;37(3):520\u20137.","journal-title":"Hepatology"},{"issue":"8","key":"10249_CR17","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","volume":"15","author":"A Tansel","year":"2017","unstructured":"Tansel A, Katz LH, El-Serag HB, et al. Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017;15(8):1207-1217.e1204.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10249_CR18","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.14309\/ajg.0000000000000715","volume":"115","author":"ND Parikh","year":"2020","unstructured":"Parikh ND, Singal AG, Hutton DW, Tapper EB. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms. Am J Gastroenterol. 2020;115(10):1642\u20139.","journal-title":"Am J Gastroenterol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10249-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T02:04:09Z","timestamp":1638929049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10249-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10249"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10249-9","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lun-Jie Yan, Sheng-Yu Yao, Guang-Xiao Meng, Kai-Xuan Liu, Hai-Chao Li, Zi-Niu Ding, Zhao-Ru Dong, Jian-Guo Hong, Zhi-Qiang Chen and Tao Li declare no conflict of interests for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}